NANETS Treatment Guidelines Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas

被引:406
作者
Kulke, Matthew H. [1 ]
Anthony, Lowell B. [2 ]
Bushnell, David L. [3 ]
de Herder, Wouter W. [4 ]
Goldsmith, Stanley J. [5 ]
Klimstra, David S. [6 ]
Marx, Stephen J. [7 ]
Pasieka, Janice L. [8 ]
Pommier, Rodney F. [9 ]
Yao, James C. [10 ]
Jensen, Robert T. [11 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Louisiana State Univ, Div Hematol Oncol, Hlth Sci Ctr, New Orleans, LA USA
[3] Univ Iowa Hosp & Clin, Dept Radiol, Iowa City, IA 52242 USA
[4] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands
[5] Cornell Univ, Div Nucl Med, Dept Radiol, New York Presbyterian Hosp,Weill Med Coll, Ithaca, NY 14853 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[7] NIDDKD, Metab Dis Branch, NIH, Bethesda, MD 20892 USA
[8] Univ Calgary, Dept Surg, Calgary, AB, Canada
[9] Oregon Hlth & Sci Univ, Div Surg Oncol, Dept Gen Surg, Portland, OR 97201 USA
[10] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[11] NIH, Digest Dis Branch, Bethesda, MD 20892 USA
关键词
islet cell; gastric; carcinoid; guidelines; review; ZOLLINGER-ELLISON-SYNDROME; MULTIPLE ENDOCRINE NEOPLASIA; SOMATOSTATIN-RECEPTOR SCINTIGRAPHY; GASTRIC CARCINOID-TUMORS; PROTON-PUMP INHIBITORS; ISLET-CELL-CARCINOMA; DUODX AFFECT RATE; PHASE-II TRIAL; LONG-TERM; LIVER METASTASES;
D O I
10.1097/MPA.0b013e3181ebb168
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.
引用
收藏
页码:735 / 752
页数:18
相关论文
共 187 条
[41]   Bone metastases in patients with gastrinomas: A prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their defection, frequency, location, and effect of their detection on management [J].
Gibril, F ;
Doppman, JL ;
Reynolds, JC ;
Chen, CC ;
Sutliff, VE ;
Yu, F ;
Serrano, J ;
Venzon, DJ ;
Jensen, RT .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1040-1053
[42]   Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours [J].
Gibril, F ;
Jensen, RT .
DIGESTIVE AND LIVER DISEASE, 2004, 36 :S106-S120
[43]   Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome - A prospective study of 107 cases and comparison with 1009 cases from the literature [J].
Gibril, F ;
Schumann, M ;
Pace, A ;
Jensen, RT .
MEDICINE, 2004, 83 (01) :43-83
[44]   Metastatic gastrinomas: Localization with selective arterial injection of secretin [J].
Gibril, F ;
Doppman, JL ;
Chang, R ;
Weber, HC ;
Termanini, B ;
Jensen, RT .
RADIOLOGY, 1996, 198 (01) :77-84
[45]   Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas - A prospective study [J].
Gibril, F ;
Reynolds, JC ;
Doppman, JL ;
Chen, CC ;
Venzon, DJ ;
Termanini, B ;
Weber, C ;
Stewart, CA ;
Jensen, RT .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (01) :26-+
[46]  
Gibril F, 1999, J NUCL MED, V40, P539
[47]  
Gibril F, 2000, J NUCL MED, V41, P1646
[48]   Advances in evaluation and management of gastrinoma in patients with Zollinger-Ellison syndrome [J].
Gibril F. ;
Jensen R.T. .
Current Gastroenterology Reports, 2005, 7 (2) :114-121
[49]   Zollinger-Ellison syndrome revisited: Diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion [J].
Gibril F. ;
Jensen R.T. .
Current Gastroenterology Reports, 2004, 6 (6) :454-463
[50]   Diazoxide treatment for insulinoma: a national UK survey [J].
Gill, GV ;
Rauf, O ;
MacFarlane, IA .
POSTGRADUATE MEDICAL JOURNAL, 1997, 73 (864) :640-641